Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results

WINDLAS BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 24.5314.888.579.11-

What is the latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH is 24.53 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202524.53
Mar202414.88
Mar20238.57
Mar20229.11
Mar2021-

How is Price to Cash Earnings (PCE) of WINDLAS BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 24.53
64.85
Mar2024 14.88
73.63
Mar2023 8.57
-5.93
Mar2022 9.11
0
Mar2021 0 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹2,114.4 Cr -0.7% -5.7% 9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,497.0 Cr 0.5% -2.3% -12.5% Stock Analytics
DIVIS LABORATORIES ₹161,787.0 Cr 0.9% -0.8% 10.8% Stock Analytics
CIPLA ₹125,870.0 Cr -0.3% -0.9% -3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,591.0 Cr -3% -2.4% 3.8% Stock Analytics
DR REDDYS LABORATORIES ₹109,380.0 Cr 0.6% 3.9% -0.4% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.7%

-5.7%

9.3%

SENSEX

1.6%

2.3%

1.1%


You may also like the below Video Courses